Outsourced Denial Management vs In-House Billing Teams

Payers denied 11.8% of claims outright in 2024, up from 11.5% the year before, according to Healthcare Finance News data. The headline number matters less than what's inside it: medical necessity denial dollar amounts jumped 70% between 2024 and 2025, and outpatient coding denials climbed 26% in the same window. Payers are also moving faster, and faster decisions have not proven fairer. Decisions that once took a human reviewer three to five business days now come back in hours, courtesy of AI-driven review, and the AMA's 2025 Prior Authorization Survey found those faster decisions carry denial rates 40% higher than the human-reviewed ones they replaced. That's the fact this piece is built around: most practices are still staffed and structured for a slower, more forgiving version of this fight, and the gap between that staffing and what payers now do is where the money disappears.

Medicare Advantage denial rates, both initial and final, run more than double the rate for traditional Medicare. The billing team that handled a manageable caseload in 2022 is now working a bigger, faster, more clinically tangled pile of denials with the same headcount, the same templates, and often the same blind spots. The real question is whether the in-house team, as staffed right now, has the speed, the memory, and the payer-specific knowledge to keep pace with what payers are doing this year, not what they were doing three years ago.

What an in-house billing team actually costs once you count everything

The number on the org chart is deceptively small. A medical billing specialist's base salary already represents a substantial fixed cost before benefits, payroll taxes, or paid leave enter the picture, all of which meaningfully push the loaded cost higher. Layer in compliance training, clearinghouse fees, billing software subscriptions, and whatever slice of a practice manager's time goes toward supervising the billing function, and the visible budget line already looks thin.

The invisible costs are worse, and they're the ones that actually decide whether in-house billing is cheap or just cheap-looking. Denial write-offs and staff turnover routinely push the real total well above what shows up in the budget. Write-offs are the biggest offender by far, since industry data consistently shows that a substantial share of denied claims never get reworked at all. That revenue is gone, permanently, and it never shows up as a line item anywhere because it was never collected in the first place. Even the claims that do get worked aren't free; reworking a single denial carries its own meaningful cost in staff time and overhead, depending on complexity.

Here's the plain conclusion: most practices are running a budget that only counts what they can see. Payroll is visible, while a denied claim quietly written off in month four is not, and that asymmetry is exactly why in-house billing costs get undercounted so consistently, year after year, at nearly every practice that hasn't gone looking for the gap on purpose.

How staff turnover destroys billing institutional memory

Payer policy doesn't hold still. An appeal template that got an Aetna denial overturned six months ago might do nothing today, because the underlying policy shifted without any formal notice reaching the practice. Knowledge like which CPT bundles a given payer flags, which appeal language actually works, which prior auth pathway clears fastest, lives almost entirely in the head of whoever has done the job long enough to have seen the pattern firsthand.

When that person leaves, the knowledge leaves with them. The replacement starts over, payer by payer, and during that relearning stretch denial rates climb while appeals get weaker, because nobody left in the building remembers what worked last time. This isn't hypothetical: the knowledge gap exists even among billers who've held the seat for years, turnover or not.

The overturn data makes the cost of that gap concrete, and it should stop anyone from treating appeals as a lost cause. Sixty-seven percent of Medicare Advantage prior auth denials get overturned on appeal; in Medicaid managed care, it's 47%. Those numbers only apply to appeals that actually get filed, correctly, with the right documentation attached, which is precisely the step institutional memory loss breaks. An outsourced denial management firm accumulates payer intelligence across every client and every claim it touches, so the knowledge compounds instead of resetting every time someone hands in a two-week notice. Altair's Memory system formalizes that same idea: it learns how each payer behaves from every claim it processes, so pattern recognition doesn't depend on one employee staying put for five years.

Ask the practical question directly: when the last biller walked out the door, did the payer-specific knowledge stay behind, or did it walk out too? Most practices have never actually checked.

Why real-time claim visibility changes what a practice can actually do about denials

Most practices find out their denial rate at month-end, which is exactly the wrong time to find out anything. By then, timely filing windows have narrowed, and some claims are already too old to fix. Industry data has put average AR days across provider organizations at 56.9, versus 43.6 for the top decile of performers. That 13-day gap is a visibility problem; MGMA's benchmark says no more than 25% of total AR should sit past 90 days, and across a benchmarking database of more than 2,100 facilities, not a single organization currently hits that mark, with the market-wide figure now north of 35%.

Every claim that fails on first submission adds 15 to 30 days to that claim's effective AR cycle, and the clock starts before anyone at the practice knows there's a problem. A denial caught and corrected the same day it lands can be resubmitted before it ages into a filing issue, while a denial discovered at month-end close is often already halfway to a write-off by the time anyone looks at it.

The structural issue is that most in-house teams see claim status through practice management system reports, something a person has to pull, open, and interpret, rather than a live feed showing where every claim actually sits right now. Altair Live closes that gap directly: it gives the practice owner a real-time view of every claim and every dollar as it moves, instead of a monthly summary assembled after the damage is done. So the question worth asking is blunt: does the current setup say, today, which claims denied yesterday and who is working them right now? If the honest answer is "we'd have to check," that's the visibility gap, in one sentence.

The denial response speed gap between in-house teams and outsourced firms

That 60% rework failure rate isn't abstract; it's what happens when denials arrive faster than a billing team can work through them. In a typical in-house setup, a denial lands in a queue or worklist, and the person responsible for it might be juggling three other priorities, might be out on leave, or might not work there anymore.

The stakes per denial keep climbing, too. The average dollar value of denied inpatient claims rose 12% year over year, and outpatient denials rose 14%, so the revenue riding on each individual denial is bigger than it was even two years ago. Prior auth denials show speed mattering more than almost anything else: they're rarely appealed at all, but when they are, overturn rates run high, 67% for Medicare Advantage, 47% for Medicaid managed care. The limiting factor was never whether the appeal would work; it's whether anyone files it, and files it fast enough to matter before the window closes.

Outsourced firms running AI tooling ingest every 835 remittance, classify each denial by its CARC and RARC codes, and route anything correctable straight to resubmission, with no worklist and no queue sitting untouched on someone's desk for a week. That speed advantage scales with size: a firm working denials across many practices spots a new payer policy shift faster than a single in-house team that only ever sees its own claims come through. The direction of the speed advantage for outsourced firms is consistent across the industry, even if precise figures vary by vendor and methodology.

Ask it plainly: when a denial lands today, what's the actual expected time between receipt and corrected resubmission? If nobody in the building can answer that in one sentence, that's the answer.

Where in-house teams have a real edge and where that edge runs out

In-house billing still earns its place in plenty of practices. A biller embedded in the practice knows the patient population, the payer mix, and the clinical context behind a complicated claim in a way no outside firm can replicate from a distance. That same biller can walk down the hall, grab documentation straight from the treating clinician, resolve an eligibility question before the patient checks in, and flag a prior auth issue while the visit is still on the schedule.

For a practice with a narrow payer mix and staff who've stuck around for years, the institutional memory problem described above is manageable, since stability solves it quietly, without anyone having to build a system around it. The trouble is that stability of that kind is rare, and getting rarer as billing roles turn over faster across the industry than they used to.

Where the edge actually runs out is volume, and it runs out faster than most practice owners expect. One or two billers can handle a clean, low-denial claim stream just fine; they cannot keep pace once denials grow more frequent and more clinically tangled without something giving, usually speed, sometimes accuracy. The edge also runs out the moment a policy change hits several payers at once: an in-house team finds out reactively, through a stack of denials that arrived before anyone connected the dots, while a firm running dedicated policy-tracking infrastructure catches the shift before claims ever go out the door. Specialty practices feel this hardest, since mental health, cardiology, and physical therapy all carry payer-specific prior auth and medical necessity rules that shift often enough that keeping up requires more than one person's part-time attention, no matter how good that person is.

In-house billing works when the conditions that make it work, low volume, low turnover, a narrow payer mix, are actually present in the practice. The honest exercise is checking whether they are, rather than assuming they still hold from three years ago.

How to assess which model is losing your practice money right now

Four numbers settle most of this argument: clean claim rate, denial rate, AR days, and the percentage of denied claims that actually get worked. Clean claim rate should sit at 95% or above, with the best-performing practices pushing toward 98%. Denial rate belongs below 5%, ideally under 3%, and AR days should land at or below an appropriate target for a practice's size and payer mix.

Beyond those numbers, three questions expose where the money is actually leaking, and they're worth asking out loud rather than assuming the answer. On institutional memory: when did the last biller leave, and what happened to the denial rate in the 60 days that followed? Is there a written, payer-specific appeal template on file, or does that knowledge live in one person's head, walking distance from the door? On visibility: how fast does a denial actually surface, same day, end of week, or only at month-end close, and who specifically owns tracking every open claim right now, by name? On speed: what share of denials get worked within five business days of arriving, and how much revenue did last quarter's unworked denials represent?

If the four numbers hit benchmark and those questions have confident, specific answers, the in-house model is doing its job, and there's no case for changing it. If any one of the three, memory, visibility, or speed, comes back uncertain, that uncertainty already has a dollar figure attached to it, whether or not anyone's calculated it yet. Altair's approach targets all three at once: Altair Clear checks every claim against current payer policy before it's ever submitted, Altair Memory builds payer-specific intelligence from every claim processed, and Altair Live gives the practice a real-time view of every claim and every dollar in motion, without adding headcount or forcing an EMR switch.

The choice here was never about which model sounds better on paper. A practice that can't answer those diagnostic questions with confidence is already losing money today, and the choice between in-house and outsourced is a choice about how to stop that loss, nothing more complicated than that.